Case Report
International Journal of Impotence Research (2004) 16, 95–97. doi:10.1038/sj.ijir.3901154
Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole
E L Rhoden1,2 and A Morgentaler1
1Division of Urology, Beth Israel Deaconess Medical Center, Men's Health Boston, Harvard Medical School, Massachusetts, USA
Correspondence: EL Rhoden, Rua Jaragua 370/302, Bela Vista 90450-140, Porto Alegre, RS, Brazil. E-mail: ernanirhoden@yahoo.com.br; A Morgentaler, One Brookline Place, 624, Brookline, MA 02445, USA. E-mail: amorgent@caregroup.harvard.edu
2Supported by CAPES-Brazil (Government Foundation for Development of Postgraduation courses in Brazil).
Received 20 August 2003; Revised 2 October 2003; Accepted 14 October 2003.
Abstract
Gynecomastia is an unusual side effect associated with testosterone replacement therapy (TRT) that has been traditionally treated with surgery, radiation, or discontinuation of testosterone supplementation. We report here our experience with two cases of gynecomastia in men undergoing TRT who were successfully treated with the aromatase inhibitor anastrozole.
Keywords:
anastrozole, hypogonadism, testosterone, risks, gynecomastia, aging male
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
International Journal of Impotence Research Review
Testosterone replacement therapy for late-onset hypogonadism
Nature Clinical Practice Urology Review (01 May 2006)
Testosterone replacement therapy for late-onset hypogonadism
Nature Clinical Practice Urology Review (01 May 2006)
RESEARCH
International Journal of Impotence Research Original Article
International Journal of Impotence Research Original Article
